Aliases & Classifications for Lymphatic System Disease

MalaCards integrated aliases for Lymphatic System Disease:

Name: Lymphatic System Disease 12 15 17
Lymphatic Diseases 44 45 74
Adenopathy 12 15
Disorder of Lymph Node and Lymphatics 12
Abnormality of the Lymphatic System 30
Disorder of Lymphatic System 12
Disorder of Lymphoid System 12
Disease of Lympoid System 12
Lympoid System Disease 12
Lymphatic Disorder 12
Lymphatic Disease 12
Lymphangiopathy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:75
MeSH 45 D008206
SNOMED-CT 69 3305006
UMLS 74 C0024228

Summaries for Lymphatic System Disease

MedlinePlus : 44 The lymphatic system is a network of tissues and organs. It is made up of Lymph - a fluid that contains white blood cells that defend against germs Lymph vessels - vessels that carry lymph throughout your body. They are different from blood vessels. Lymph nodes - glands found throughout the lymph vessels. Along with your spleen, these nodes are where white blood cells fight infection. Your bone marrow and thymus produce the cells in lymph. They are part of the system, too. The lymphatic system clears away infection and keeps your body fluids in balance. If it's not working properly, fluid builds in your tissues and causes swelling, called lymphedema. Other lymphatic system problems can include infections, blockage, and cancer.

MalaCards based summary : Lymphatic System Disease, also known as lymphatic diseases, is related to histiocytosis and hemophagocytic lymphohistiocytosis, and has symptoms including edema, axillary lymph node pain and axillary lymph node tenderness. An important gene associated with Lymphatic System Disease is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways are Innate Immune System and Tight junction. The drugs Methotrexate and Prednisone have been mentioned in the context of this disorder. Affiliated tissues include b cells, t cells and bone, and related phenotypes are no effect and hematopoietic system

Disease Ontology : 12 An immune system disease that is located in the lymphatic system.

Wikipedia : 77 Lymphatic disease is a class of disorders which directly affect the components of the lymphatic... more...

Related Diseases for Lymphatic System Disease

Diseases related to Lymphatic System Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)
# Related Disease Score Top Affiliating Genes
1 histiocytosis 31.9 CD1A CD207 SERPINA3 TNFRSF8
2 hemophagocytic lymphohistiocytosis 31.6 CD5 IL10 PRF1 STX11 STXBP2 UNC13D
3 pulmonary sarcoidosis 11.3
4 periodic fever, aphthous stomatitis, pharyngitis and adenitis 11.3
5 follicular lymphoma 11.1
6 systemic onset juvenile idiopathic arthritis 11.1
7 mycosis fungoides 11.0
8 hyper-igd syndrome 11.0
9 astrakhan spotted fever 11.0
10 indian tick typhus 11.0
11 israeli tick typhus 11.0
12 far eastern spotted fever 11.0
13 flinders island spotted fever 11.0
14 japanese spotted fever 11.0
15 mesenteric lymphadenitis 11.0
16 siberian tick typhus 11.0
17 boutonneuse fever 11.0
18 hennekam syndrome 11.0
19 lymphangitis 11.0
20 lymphatic malformation 1 10.9
21 yellow nail syndrome 10.9
22 lymphangiectasia, pulmonary, congenital 10.9
23 alk+ histiocytosis 10.5 CD1A CD207
24 good syndrome 10.5 STX11 UNC13D
25 langerhans cell sarcoma 10.5 CD1A CD207
26 nodular tenosynovitis 10.4 CD68 SERPINA3
27 congenital lymphedema 10.4 FLT4 FOXC2
28 multifocal motor neuropathy 10.4 CD1A CD1E
29 eye lymphoma 10.4 CD5 IL10
30 inflammatory mfh 10.4 CD68 SERPINA3
31 macrophage activation syndrome 10.4 PRF1 UNC13D
32 hemophagocytic lymphohistiocytosis, familial, 4 10.4 STX11 STXBP2 UNC13D
33 scrotal carcinoma 10.4 CD68 SERPINA3
34 sternum cancer 10.4 CD68 TNFRSF8
35 dendritic cell tumor 10.3 CD1A CD207 CD68
36 conventional fibrosarcoma 10.3 CD68 TNFRSF8
37 chylothorax, congenital 10.3 FLT4 FOXC2
38 lichen nitidus 10.3 CD68 TNFRSF8
39 autoimmune lymphoproliferative syndrome 10.3 IL10 PRF1 UNC13D
40 hodgkin's lymphoma, lymphocytic depletion 10.3 CD68 TNFRSF8
41 t-cell/histiocyte rich large b cell lymphoma 10.3 CD68 TNFRSF8
42 colon lymphoma 10.3 CD5 TNFRSF8
43 granulomatous myositis 10.3 CD68 TNFRSF8
44 plasma protein metabolism disease 10.3 CD5 SERPINA3
45 hereditary lymphedema 10.3 FLT4 FOXC2
46 lymph node disease 10.3 CA8 IL10 PGLS
47 pharyngitis 10.3
48 stomatitis 10.3
49 epidural neoplasm 10.3 CD5 TNFRSF8
50 aphthous stomatitis 10.2

Graphical network of the top 20 diseases related to Lymphatic System Disease:



Diseases related to Lymphatic System Disease

Symptoms & Phenotypes for Lymphatic System Disease

UMLS symptoms related to Lymphatic System Disease:


edema, axillary lymph node pain, axillary lymph node tenderness

GenomeRNAi Phenotypes related to Lymphatic System Disease according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 no effect GR00402-S-1 9.92 CA8 CCR6 CD1A CD1B CD1C CD1D

MGI Mouse Phenotypes related to Lymphatic System Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 CCR6 CD1D CD207 CD5 CD68 IL10
2 immune system MP:0005387 9.44 CCR6 CD1D CD207 CD5 CD68 FLT4

Drugs & Therapeutics for Lymphatic System Disease

Drugs for Lymphatic System Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1073)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1959-05-2, 59-05-2 126941
2
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
3
Azathioprine Approved Phase 4,Phase 3,Early Phase 1 446-86-6 2265
4
Azithromycin Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 83905-01-5 447043 55185
5
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703
6
Cytarabine Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 147-94-4, 65-46-3 6253
7
Daunorubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 20830-81-3 30323
8
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1177-87-3
9
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-02-2 5743
10
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
11
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
12
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 75607-67-9, 21679-14-1 30751
13
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
14
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
15
Thioguanine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 154-42-7 2723601
16
Mercaptopurine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-44-2 667490
17
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
18
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
19
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 2068-78-2, 57-22-7 5978
20
Dasatinib Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 302962-49-8 3062316
21
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
22
Idarubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58957-92-9 42890
23
Riociguat Approved Phase 4 625115-55-1
24
Vinblastine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 865-21-4 241903 13342
25
Pegaspargase Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 130167-69-0
26
Cladribine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4291-63-8 20279
27
Vindesine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53643-48-4, 59917-39-4 40839
28
Teniposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 29767-20-2 34698
29
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
30
Sargramostim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 123774-72-1, 83869-56-1
31
rituximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
32
Hydroxocobalamin Approved Phase 4,Phase 3,Phase 2,Phase 1 13422-51-0 15589840 11953898
33
Methylcobalamin Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1 13422-55-4
34
Ferrous succinate Approved Phase 4 10030-90-7
35
Iron Approved, Experimental Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 7439-89-6, 15438-31-0 27284 23925
36
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 95058-81-4 60750
37
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 15663-27-1 2767 441203 84093
38
Epirubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 56420-45-2 41867
39
Oxaliplatin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 61825-94-3 43805 6857599 5310940 9887054
40
Tenofovir Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147127-20-6 464205
41
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 3778-73-2 3690
42
Entecavir Approved, Investigational Phase 4,Phase 2,Not Applicable 142217-69-4 153941
43
Mesna Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 3375-50-6 598
44
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-75-2 4033
45
Pentostatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53910-25-1 439693 40926
46
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-61-7 60961
47
Vidarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 24356-66-9 21704 32326
48
Methylphenidate Approved, Investigational Phase 4,Not Applicable 113-45-1 4158
49
Dopamine Approved Phase 4,Phase 1,Not Applicable 62-31-7, 51-61-6 681
50
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-78-2 2244

Interventional clinical trials:

(show top 50) (show all 7444)
# Name Status NCT ID Phase Drugs
1 Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) Unknown status NCT01830959 Phase 4 Roflumilast;Placebo
2 Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) Unknown status NCT02188017 Phase 4 Acthar gel
3 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
4 Low Grade Lymphoma Unknown status NCT01698866 Phase 4
5 PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation Unknown status NCT02905942 Phase 4 PEG-rhG-CSF;rhG-CSF
6 Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study Unknown status NCT02894645 Phase 4 Prednisolone;Dexamethasone;L-Asparaginase;Vincristine;Methotrexate;Daunorubicin;Doxorubicin;Cyclophosphamide;Cytarabine;6-Mercaptopurine;Thioguanine;Fludarabine;Imatinib
7 Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients Unknown status NCT02690922 Phase 4 Dasatinib;prednisone;dexamethasone;methotrexate
8 HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL Unknown status NCT01873807 Phase 4 IDA;CTX;VP-16
9 Riociguat for Sarcoidosis Associated Pulmonary Hypertension Unknown status NCT02625558 Phase 4 Riociguat;Placebo
10 Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma Unknown status NCT01088750 Phase 4 cyclophosphamide;prednisolone;vinblastine sulfate
11 The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia Unknown status NCT00846703 Phase 4 6-mercaptopurine, Methotrexate;6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone
12 Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 Unknown status NCT00222612 Phase 4 Standard childhood UK ALL protocol;Intensified treatment including Capizzi maintenance
13 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Unknown status NCT00198991 Phase 4 Cyclophosphamide;Dexamethasone;Vincristine;daunorubicin;Asparaginase;Methotrexate;Cytarabine;Mercaptopurine;G-CSF;Vindesine;VP16;Prednisolone;Adriamycin;Thioguanine;VM26;Idarubicin;Fludarabine;Cladribine
14 German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Unknown status NCT00198978 Phase 4 Cyclophosphamide;Dexamethasone / Prednisolone;Cytarabine;Idarubicin;Granulocyte-Colony-Stimulating Factor;Mercaptopurine;Methotrexate;Rituximab;HDARAC;Vincristine;Depocyte;Asparaginase
15 Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses Unknown status NCT00192673 Phase 4 PEG-asparaginase
16 Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation Unknown status NCT03010579 Phase 4 erythropoietin;iron supplementation
17 PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia Unknown status NCT02996617 Phase 4 rhG-CSF regimen;Pegylated rhG-CSF regimen
18 To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma Unknown status NCT02585947 Phase 4 Tenofovir
19 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
20 Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Unknown status NCT01990807 Phase 4 Idarubicin(IDA)
21 Treatment of Diffuse Large B Cell Lymphoma Unknown status NCT01949818 Phase 4 Yangzhengxiaoji capsule combined with CHOP regimen;CHOP regimen
22 Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy Unknown status NCT01768195 Phase 4 Entecavir prophylaxis
23 Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma Unknown status NCT01765231 Phase 4 Entecavir prophylaxis;Observation arm
24 Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ Unknown status NCT01501149 Phase 4 DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase);Modified SMILE (MTX,DEX,IFO,L-ASP,Etoposide,Mesna)
25 Treatment of Natural Killer/T Cell Lymphoma-I/II Unknown status NCT01501136 Phase 4
26 Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults Unknown status NCT00797810 Phase 4 Rituximab
27 Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Unknown status NCT00131313 Phase 4 Nipent, Cytoxan, Rituxan
28 Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET Unknown status NCT00188149 Phase 4 Combined chemotherapy (ABVD, BACOPP-D)
29 CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors Unknown status NCT00399399 Phase 4 azathioprine;cyclophosphamide
30 Effectiveness of Intracavitary Manual Lymphatic Drainage Completed NCT02960841 Phase 4
31 Comparison Between a Non-elastic Falcro Device and Current Method After Total Knee Arthroplasty Completed NCT02375945 Phase 4
32 Lymphedema Study for Arm or Leg Lymphedema Completed NCT02257970 Phase 4 Ketoprofen;Placebo
33 A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction Completed NCT01561287 Phase 4
34 Short Term Effectiveness Study of Juxta-Fit Versus Trico Bandages in the Treatment of Leg Lymphedema Completed NCT01068431 Phase 4
35 A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection Completed NCT02476357 Phase 4
36 Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD) Completed NCT01088724 Phase 4 fludarabine, cyclophosphamide, doxorubicin, rituximab
37 A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies Completed NCT00776425 Phase 4 Epoetin beta
38 Use of Focalin for Fatigue in Sarcoidosis Completed NCT00361387 Phase 4 d-methylphenidate
39 OK432 (Picibanil) in the Treatment of Lymphatic Malformations Completed NCT03427619 Phase 4 OK432
40 Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy Completed NCT02246023 Phase 4
41 Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome Completed NCT00563771 Phase 4 Rasburicase
42 Rasburicase in Tumor Lysis Syndrome Completed NCT00302653 Phase 4 Rasburicase
43 Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Completed NCT00520494 Phase 4 Vivaglobin
44 PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy Completed NCT02805218 Phase 4 PEG-rhG-CSF
45 An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Completed NCT02782845 Phase 4 Chemotherapy;Immunochemotherapy;Pegfilgrastim
46 Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease Completed NCT01524939 Phase 4 immunoglobulin G
47 Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia Completed NCT01358253 Phase 4 Cyclophosphamide;Doxorubicin;Vincristine;Dexamethasone;Cytarabine;Methotrexate;Rituximab;6-Mercaptopurine;Prednisone;L-asparaginase
48 Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma Completed NCT01180049 Phase 4 temsirolimus;temsirolimus
49 Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms Completed NCT01164475 Phase 4 Granulocyte-colony stimulating factor (G-CSF);Fixed Dose Plerixafor;Weight-Based Plerixafor
50 Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma Completed NCT01124526 Phase 4 Rituximab Fludarabine Cyclophosphamide

Search NIH Clinical Center for Lymphatic System Disease

Cochrane evidence based reviews: lymphatic diseases

Genetic Tests for Lymphatic System Disease

Genetic tests related to Lymphatic System Disease:

# Genetic test Affiliating Genes
1 Abnormality of the Lymphatic System 30

Anatomical Context for Lymphatic System Disease

MalaCards organs/tissues related to Lymphatic System Disease:

42
B Cells, T Cells, Bone, Breast, Bone Marrow, Myeloid, Lymph Node

The Foundational Model of Anatomy Ontology organs/tissues related to Lymphatic System Disease:

20
The Lymphatic System

Publications for Lymphatic System Disease

Articles related to Lymphatic System Disease:

# Title Authors Year
1
Use of Unenhanced MR Lymphography to Characterize Lung Lymphatic Diseases. ( 28639922 )
2017
2
Reply to "Use of Unenhanced MR Lymphography to Characterize Lung Lymphatic Diseases". ( 28639923 )
2017
3
Imaging of thoracic lymphatic diseases. ( 19933641 )
2009
4
Lymphatic diseases. ( 1735059 )
1992
5
Heterochromatin and nucleolus organizer regions in cells of patients with malignant and premalignant lymphatic diseases. ( 6490006 )
1984
6
Skin and diabetes. III. Incidence of diabetes in a group of patients with skin disorders caused by venous and/or lymphatic diseases of the leg. ( 4470105 )
1974
7
CONGENITAL LYMPHATIC DISEASES-LYMPHANGIOMATA. ( 17857001 )
1937

Variations for Lymphatic System Disease

Expression for Lymphatic System Disease

Search GEO for disease gene expression data for Lymphatic System Disease.

Pathways for Lymphatic System Disease

GO Terms for Lymphatic System Disease

Cellular components related to Lymphatic System Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.98 CCR6 CD1A CD1C CD1D CD1E CD5
2 lysosome GO:0005764 9.77 CD1B CD1C CD1D CD1E UNC13D
3 cell surface GO:0009986 9.5 CCR6 CD1B CD1D
4 cytolytic granule GO:0044194 9.4 PRF1 STXBP2
5 endosome membrane GO:0010008 9.35 CD1A CD1B CD1C CD1D CD68
6 endosome GO:0005768 9.23 CD1A CD1B CD1C CD1D CD1E CD68
7 membrane GO:0016020 10.33 CCR6 CD1A CD1B CD1C CD1D CD1E
8 integral component of membrane GO:0016021 10.1 CCR6 CD1A CD1B CD1C CD1D CD1E
9 plasma membrane GO:0005886 10 CCR6 CD1A CD1B CD1C CD1D CD1E

Biological processes related to Lymphatic System Disease according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 9.88 CD1A CD1B CD1C CD1D CD1E
2 immune response GO:0006955 9.8 CCR6 CD1A CD1B CD1C CD1D CD1E
3 adaptive immune response GO:0002250 9.76 CD1A CD1B CD1C CD1E
4 exocytosis GO:0006887 9.67 STX11 STXBP2 UNC13D
5 regulation of immune response GO:0050776 9.62 CD1A CD1B CD1C CD1D
6 positive regulation of T cell mediated cytotoxicity GO:0001916 9.55 CD1A CD1B CD1C CD1D CD1E
7 lymph vessel development GO:0001945 9.43 FLT4 FOXC2
8 lymphangiogenesis GO:0001946 9.4 FLT4 FOXC2
9 regulation of mast cell degranulation GO:0043304 9.37 STXBP2 UNC13D
10 antigen processing and presentation, exogenous lipid antigen via MHC class Ib GO:0048007 9.35 CD1A CD1B CD1C CD1D CD1E
11 antigen processing and presentation, endogenous lipid antigen via MHC class Ib GO:0048006 9.02 CD1A CD1B CD1C CD1D CD1E

Molecular functions related to Lymphatic System Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 lipopeptide binding GO:0071723 9.55 CD1A CD1B CD1C CD1D CD1E
2 endogenous lipid antigen binding GO:0030883 9.35 CD1A CD1B CD1C CD1D CD1E
3 exogenous lipid antigen binding GO:0030884 9.02 CD1A CD1B CD1C CD1D CD1E

Sources for Lymphatic System Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....